Literature DB >> 11347675

Molecular identification of TEM-1 beta-lactamase in a Pasteurella multocida isolate of human origin.

T Naas1, F Benaoudia, L Lebrun, P Nordmann.   

Abstract

Two clinical strains of Pasteurella multocida were isolated from an HIV-infected patient who developed arthritis. Strain FB-1, which was isolated from a dog-bite wound, was resistant to narrow-spectrum penicillins. The second strain, FB-2, which was present in blood cultures as well as the dog-bite wound, was susceptible to all beta-lactam agents. Arbitrarily primedpolymerase chain reaction and pulsed-field gel electrophoresis revealed that these two isolates were genetically indistinguishable. 16S rDNA gene sequencing facilitated identification at the subspecies level. Amoxicillin resistance determinant was located on a highly unstable 4.3-kb plasmid, pFAB-1. Isoelectrofocusing and polymerase chain reaction amplification followed by sequencing revealed the presence of a pI 5.4 TEM-1 beta-lactamase. This description is the first of a TEM-1 Beta-lactamase' in a Pasteurella multocida strain of human origin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11347675     DOI: 10.1007/pl00011254

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound.

Authors:  T J Albert; D L Stevens
Journal:  Infection       Date:  2010-07-10       Impact factor: 3.553

2.  Pasteurella multocida meningoencephalitis in an immunocompetent adult with multiple cat scratches.

Authors:  David Alistair Clarke; Angela Mcbride; Michael Kelsey; Ben Killingley
Journal:  BMJ Case Rep       Date:  2017-05-03

3.  Fatal fulminant sepsis due to a cat bite in an immunocompromised patient.

Authors:  Ivana Harsanji Drenjancevic; Dubravka Ivic; Domagoj Drenjancevic; Josip Ivic; Boris Pelc; Dubravka Vukovic
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 4.  Paediatric epidemiology of Pasteurella multocida meningitis in France and review of the literature.

Authors:  H Guet-Revillet; C Levy; I Andriantahina; N Kalach; M-H Pierre; A Elbez-Rubinstein; C Boniface; P Berche; R Cohen; A Ferroni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-05       Impact factor: 3.267

5.  Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.

Authors:  Alvaro San Millan; Jose Antonio Escudero; Belen Gutierrez; Laura Hidalgo; Nerea Garcia; Montserrat Llagostera; Lucas Dominguez; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

6.  Pasteurella multocida wound infection transmitted by a pet dog.

Authors:  Sofia Maraki; Grigoris Kastanis; Dimitra Stafylaki; Samer Masunt; Petros Kapsetakis; Effie Scoulica
Journal:  Germs       Date:  2018-12-03

7.  Virulence Determinants and Antimicrobial Profiles of Pasteurella multocida Isolated from Cattle and Humans in Egypt.

Authors:  Mohamed Sabry Abd Elraheam Elsayed; Samah Mahmoud Eldsouky; Tamer Roshdy; Lamia Said; Nahed Thabet; Tamer Allam; A B Abeer Mohammed; Ghada M Nasr; Mohamed S M Basiouny; Behiry A Akl; Maha M Nader; Al Shaimaa Hasan; Ahmed Salah
Journal:  Antibiotics (Basel)       Date:  2021-04-22

8.  Non-zoonotic Pasteurella multocida Infection as a Cause of Septic Shock in a Patient with Liver Cirrhosis: A Case Report and Review of the Literature.

Authors:  Jose Orsini; Ruben Perez; Alfonso Llosa; Nyale Araguez
Journal:  J Glob Infect Dis       Date:  2013-10

9.  Clinical Features and Outcomes of Pasteurella multocida Infection.

Authors:  Antonio Giordano; Toros Dincman; Benjamin E Clyburn; Lisa L Steed; Don C Rockey
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy.

Authors:  Damiano Larnè; Manuela Ceccarelli; Fabrizio Condorelli; Emmanuele Venanzi Rullo; Giuseppe Nunnari; Giovanni Francesco Pellicanò
Journal:  Infect Dis Rep       Date:  2018-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.